|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Operating activities: | |||||
| Net income | |||||
| Less: net (income) loss from discontinued operations | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Interest sensitive and index product benefits | |||||
| Amortization of deferred sales inducements | |||||
| Other policy revenue | |||||
| Accretion on investments | |||||
| Realized gains/losses on investments | |||||
| Change in fair value of derivatives | |||||
| Distributions from equity method investments | |||||
| Share-based compensation | |||||
| Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired | |||||
| Deferral of policy acquisition costs | |||||
| Amortization of deferred policy acquisition costs | |||||
| Gains on investments and derivatives | |||||
| Other losses (gains) | |||||
| Provisions for credit losses | |||||
| Income from real estate partnerships, investment funds and corporations | |||||
| Distributions from real estate partnerships, investment funds and corporations | |||||
| Interest credited to policyholders' account balances | |||||
| Change in fair value of embedded derivatives | |||||
| Change in traditional life and accident and health insurance reserves | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Insurance-related liabilities | |||||
| Premiums due and other receivables | |||||
| Funds withheld for reinsurance liabilities | |||||
| Reinsurance recoverables and deposit assets | |||||
| Accrued investment income | |||||
| Change in income taxes recoverable/payable | |||||
| Change in other assets | |||||
| Change in other policy funds and contract claims | |||||
| Change in market risk benefits, net | |||||
| Change in collateral held for derivatives | |||||
| Change in funds withheld from reinsurers | |||||
| Change in other liabilities | |||||
| Working capital and other | |||||
| Cash used by operating activities - discontinued operations | |||||
| Cash flows provided by operating activities | |||||
| Investing activities: | |||||
| Acquisition of subsidiary, net of cash acquired | |||||
| Disposition of subsidiary, net of cash disposed | |||||
| Purchase of investments: | |||||
| Available-for-sale fixed maturity securities | |||||
| Equity securities | |||||
| Mortgage loans on real estate | |||||
| Real estate investments acquired | |||||
| Private loans | |||||
| Investment real estate and real estate partnerships | |||||
| Investment funds | |||||
| Short-term investments | |||||
| Other invested assets | |||||
| Purchases of property, furniture and equipment | |||||
| Proceeds from sales and maturities of investments: | |||||
| Fixed maturity securities, available for sale | |||||
| Available-for-sale fixed maturity securities | |||||
| Equity securities | |||||
| Mortgage loans on real estate | |||||
| Real estate investments sold | |||||
| Derivative instruments | |||||
| Private loans | |||||
| Investment real estate and real estate partnerships | |||||
| Investment funds | |||||
| Short-term investments | |||||
| Other invested assets | |||||
| Purchases of derivatives | |||||
| Proceeds from sales and maturities of derivatives | |||||
| Purchase of intangibles and property and equipment | |||||
| Proceeds from sales of intangibles and property and equipment | |||||
| Purchase of equity accounted investments | |||||
| Distributions from equity accounted investments | |||||
| Change in collateral held for derivatives | |||||
| Other | |||||
| Cash from investing activities - discontinued operations | |||||
| Cash flows provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Receipts credited to annuity policyholder account balances | |||||
| Coinsurance deposits | |||||
| Return of annuity policyholder account balances | |||||
| Issuance of common equity | |||||
| Acquisition of treasury stock | |||||
| Change in checks in excess of cash balance | |||||
| Dividends paid on common stock | |||||
| Dividends paid on preferred stock | |||||
| Contributions from (distributions to) shareholders | |||||
| Issuance of preferred equity | |||||
| Redemption of preferred equity | |||||
| Dividends paid to stockholders | |||||
| Borrowings from related parties | |||||
| Repayment of borrowings to related parties | |||||
| Borrowings from external parties | |||||
| Repayment of borrowings to external parties | |||||
| Proceeds from issuance of loan payable | |||||
| Borrowings issued to reinsurance entities | |||||
| Repayment of borrowings issued to reinsurance entities | |||||
| Policyholders’ account deposits | |||||
| Policyholders’ account withdrawals | |||||
| Debt issuance costs | |||||
| Payment related to recapture of reinsurance agreement | |||||
| Issuance of equity, noncontrolling interests | |||||
| Distributions to noncontrolling interests | |||||
| Cash flows provided by financing activities | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Net change during the period | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Cash and cash equivalents, end of period | |||||
| Less: Cash and cash equivalents of discontinued operations | |||||
| Supplementary cash flow disclosure: | |||||
| Cash taxes paid (net of refunds received) | |||||
| Income tax refunds received | |||||
| Deferral of sales inducements | |||||
| Cash interest paid | |||||
| Non-cash transactions: | |||||
| Available-for-sale fixed maturity securities received in connection with pension risk transfer transactions | |||||
| Equity securities transferred as consideration paid for acquisition of a subsidiary | |||||
| Non-cash deposit on reinsurance | |||||
| Transfer of invested assets | |||||
| Available-for-sale fixed maturity securities received as proceeds from investment fund sales | |||||
| Assets reverted in connection with pension termination | |||||
| Private loans received as proceeds from other invested assets as part of common control transactions | |||||
Loading...